Honduras added 36 new cases of coronavirus this Saturday, bringing the number of infections to 627, while the number of deaths rose from 55 to 59, the National Risk Management System (Sinager) reported.
The health authorities carried out 96 new tests this day, of which 36 were positive in coronavirus, which brings the number of infections to 627, Sinager spokesman Francis Contreras said on the national network.
Of the new diagnosed cases, 32 correspond to the department of Cortés, in the north of the country, the most affected region with 464 of the total number of patients; two in Yoro (north), one in Atlántida (Caribbean) and the other in Comayagua (center), he added.
Of the total of patients affected by COVID-19, 162 are hospitalized, 147 of them are “stable”, eight serious and seven in the intensive care unit, he detailed.
Contreras said that the rest of the patients are in isolation and are being monitored by health personnel, in addition to confirming four new deceased, all in Cortes, which brought the total number of deaths due to the pandemic to 59.
He explained that so far 65 patients have been recovered from COVID-19 in the Central American country and that of the new cases 20 are men, 13 women and three children between the ages of 3 and 11.
In order to try to stop the spread of the coronavirus, the Honduran government decreed a curfew in mid-March and maintains the closure of its borders, non-necessity shops and educational centers.
The use of hydroxychloroquine and azithromycin as treatments for COVID-19 has prevented some patients from becoming critically ill, Honduran Deputy Minister of Health Roberto Cosenza said today.
“Hydroxychloroquine plus azithromycin in the early stage has been able to prevent these patients from falling into this critical stage,” he emphasized.
Honduran scientist Marco Tulio Medina agreed with Cosenza and stressed that research has been carried out with a series of drugs for the treatment of COVID-19, including hydroxychloroquine.
“The groups of scientists have concluded that chloroquine, azithromycin and hydroxychloroquine could have an important positive effect in the treatment of COVID-19,” Medina said, according to a statement from the Honduran Presidency.
He assured that Dr. Anthony Fuaci, adviser to the US President, Donald Trump, has stated that chloroquine “can be applied to patients with COVID-19 under the concept of a clinical trial and strict surveillance, and that it cannot be given without a clinical trial ”.
Hydroxychloroquine is primarily used for rheumatoid arthritis and lupus, and is licensed for use by the United States Food and Drug Administration (FDA) for COVID-19, although it is not there is scientific certainty of a potential benefit for those affected.
The scientific world has mobilized in search of a medical response to COVID-19, which has meant, among other things, that hospitals and pharmaceutical companies around the world are testing known therapies to deal with the coronavirus.